SITOCABNAGENE LOXIVELEUCEL EXPRESSED A CHIMERIC ANTIGEN RECEPTOR (CAR) TARGETING CD19 FUSED TO CD28 AND CD3 ZETA SIGNALLING DOMAINS

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

SITOCABNAGENE LOXIVELEUCEL EXPRESSED A CHIMERIC ANTIGEN RECEPTOR (CAR) TARGETING CD19 FUSED TO CD28 AND CD3 ZETA SIGNALLING DOMAINS

Preferred Name

English

Code System Code Type Description

FDA UNII

DR57VB3CAB

Created by admin on Wed Apr 02 12:54:27 GMT 2025 , Edited by admin on Wed Apr 02 12:54:27 GMT 2025

PRIMARY

SUBSTANCE RECORD


					DR57VB3CAB

SITOCABNAGENE LOXIVELEUCEL EXPRESSED A CHIMERIC ANTIGEN RECEPTOR (CAR) TARGETING CD19 FUSED TO CD28 AND CD3 ZETA SIGNALLING DOMAINS